Opinion: Buprenorphine, autism diagnoses, and long Covid: the most-read First Opinion essays of 2023

In a year of abortion restrictions, biotech industry upheaval, and revolutionary drug approvals, First Opinion strived to publish the most surprising, provocative, and conversation-starting essays from a wide variety of contributors. Below, you’ll find our top six most-read articles of the year by page views. Why six instead of five? Because why not?

And if your holiday plans mean you’re spending some time traveling, be sure to catch up with the “First Opinion Podcast,” where I speak with authors of recent First Opinion essays about their articles — and much more.

Read the rest…